TABLE 23-3.
Drug | Dosage (Cats) | C: Contraindications DI: Drug Interactions DA: Dosage Adjustments |
---|---|---|
Metoclopramide | 0.2-0.4 mg/kg SC, PO q8h 1-2 mg/kg/day CRI |
C: GI obstruction DI: Phenothiazines: extrapyramidal signs DA: Azotemia |
Dolasetron Ondansetron |
0.5-1.0 mg/kg IV, SC, PO q12-24h 0.22-0.5 mg/kg IV, PO q8-12h |
DI: Cisapride: prolonged QT interval and arrhythmias |
Maropitant | 1 mg/kg IV, SC, PO q24h (up to 5 days) | |
Phenothiazines prochlorperazine chlorpromazine | 0.2-0.4 mg/kg SC q8h | C: Dehydration; hypotension; seizure hx DI: Metoclopramide: extrapyramidal signs |
Cisapride | 1.5 mg/kg PO q12h | C: GI obstruction DI: Dolasetron: prolonged QT interval and arrhythmias; azole antifungals: inhibition CYP3A isoenzyme |
Mirtazapine | 1.88 mg/cat PO q48h | DI: Concurrent administration with other MAO inhibitors (i.e., selegiline, amitraz, tramadol, amitriptyline, clomipramine) and/or SSRIs (i.e., fluoxetine) contraindicated DA: Kidney or liver dysfunction |
CRI, Constant rate infusion; hx, history.